PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 26 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,797 | +16.7% | 41,148 | +16.2% | 0.00% | 0.0% |
| Q2 2023 | $178,102 | +495.9% | 35,408 | +628.6% | 0.00% | – |
| Q1 2023 | $29,889 | -76.7% | 4,860 | -49.9% | 0.00% | – |
| Q4 2022 | $128,027 | – | 9,699 | +9599.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 100 | -75.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 400 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 400 | +33.3% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 300 | +50.0% | 0.00% | – |
| Q3 2021 | $3,000 | – | 200 | +700.0% | 0.00% | – |
| Q1 2021 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,499,149 | $18,814,000 | 3.39% |
| New Leaf Venture Partners, L.L.C. | 117,242 | $7,975,000 | 2.05% |
| Worth Venture Partners, LLC | 348,703 | $4,376,000 | 1.63% |
| INSPIRION WEALTH ADVISORS, LLC | 253,262 | $3,178,000 | 0.78% |
| EAM Global Investors LLC | 187,900 | $2,358,000 | 0.65% |
| EAM Investors, LLC | 279,613 | $3,509,000 | 0.54% |
| ACT CAPITAL MANAGEMENT, LLC | 45,000 | $565,000 | 0.29% |
| Andesa Financial Management Inc. | 33,310 | $418,000 | 0.13% |
| Monashee Investment Management LLC | 80,000 | $1,004,000 | 0.12% |
| Sofinnova Investments, Inc. | 142,635 | $1,790,000 | 0.10% |